Patents Assigned to ReFlow Therapeutics AG
  • SYSTEM AND METHODS FOR TREATING MVO
    Publication number: 20170189654
    Abstract: MVO is treated by introducing injectate into blood vessels affected by MVO at precise flow rates, while blocking retrograde flow, such that the natural pumping of the heart aids in forcing the injectate into the affected microvessels. Monitoring pressure distal of an occlusion balloon is used to determine treatment effectiveness and heart health.
    Type: Application
    Filed: January 4, 2017
    Publication date: July 6, 2017
    Applicant: ReFlow Therapeutics AG
    Inventors: Robert S. Schwartz, Martin T. Rothman, Jon H. Hoem